Evaluation of Potential Racial Disparities in <i>CYP2C19</i> ‐Guided P2Y <sub>12</sub> Inhibitor Prescribing After Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Evaluation of Potential Racial Disparities in CYP2C19 ‐Guided P2Y ₁₂ Inhibitor Prescribing After Percutaneous Coronary Intervention

Published:2022-11-19 Issue:3 Volume:113 Page:615-623
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin Pharma and Therapeutics

Author:

Cavallari Larisa H.¹^ORCID,Limdi Nita A.²,Beitelshees Amber L.³,Lee James C.⁴^ORCID,Duarte Julio D.¹,Franchi Francesco⁵,Tuteja Sony⁶^ORCID,Giri Jay⁶,Empey Philip E.⁷^ORCID,Kreutz Rolf P.⁸,Skaar Todd C.⁸,Allen John M.⁹,Coons James C.⁷^ORCID,Gong Yan¹^ORCID,McDonough Caitrin W.¹,Stevenson James M.⁷,Thomas Cameron D.¹^ORCID,Johnson Julie A.¹,Stouffer George A.¹⁰,Angiolillo Dominick J.⁵,Lee Craig R.¹⁰¹¹^ORCID,

Affiliation:

1. Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine University of Florida College of Pharmacy Gainesville Florida USA

2. Department of Neurology, Program for Translational Pharmacogenomics and Hugh Kaul Personalized Medicine Institute, School of Medicine University of Alabama at Birmingham Birmingham Alabama USA

3. Department of Medicine and Program for Personalized and Genomic Medicine University of Maryland School of Medicine Baltimore Maryland USA

4. Department of Pharmacy Practice University of Illinois Chicago Chicago Illinois USA

5. University of Florida College of Medicine‐Jacksonville Jacksonville Florida USA

6. University of Pennsylvania Perelman School of Medicine Philadelphia Pennsylvania USA

7. Department of Pharmacy and Therapeutics University of Pittsburgh School of Pharmacy Pittsburgh Pennsylvania USA

8. Indiana University School of Medicine Indianapolis Indiana USA

9. Department of Pharmacotherapy and Translational Research University of Florida College of Pharmacy Orlando Florida USA

10. Division of Cardiology and McAllister Heart Institute University of North Carolina Chapel Hill North Carolina USA

11. Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill North Carolina USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2776

Reference40 articles.

1. The State of US Health, 1990-2016

2. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials

3. Antiplatelet therapy after percutaneous coronary intervention

4. Does Black Ethnicity Influence the Development of Stent Thrombosis in the Drug-Eluting Stent Era?

5. Prognostic Impact of Race in Patients Undergoing PCI

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CYP2C19 Genetic Testing for Oral P2Y12 Inhibitor Therapy: A Scientific Statement From the American Heart Association;Circulation;2024-08-06

2. CYP2C19 Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary Intervention;Journal of the American Heart Association;2024-06-18

3. From genes to drugs: CYP2C19 and pharmacogenetics in clinical practice;Frontiers in Pharmacology;2024-02-14

4. Diversity, Equity, and Inclusion: Translating Clinical Pharmacology for All;Clinical Pharmacology & Therapeutics;2023-02-16